RT Journal Article
SR Electronic
T1 Different Combinations of the Metabolic Syndrome Criteria and Cardiovascular Disease
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.10.11.23296877
DO 10.1101/2023.10.11.23296877
A1 Lind, Lars
YR 2023
UL http://medrxiv.org/content/early/2023/10/12/2023.10.11.23296877.abstract
AB Background The metabolic syndrome (MetS) has previously been linked to incident cardiovascular disease (CVD). It is however not known if certain combinations of MetS criteria show a higher risk than others.Methods We used data from UK biobank in which 388,800 individuals had data on MetS using the five harmonized NCEP criteria. The cohort was followed for a median of 12.6 years. A composite CVD outcome was used (myocardial infarction, ischemic stroke or heart failure).Results The risk of incident CVD (n= 22,572) increased in a fairly linear fashion with increasing number of MetS criteria. In the groups showing three MetS criteria, thus fulfilling the definition of MetS, the highest risk was seen in those with the combination of the glucose + waist circumference + HDL criteria (HR 3.90, 95%CI 3.17-4.80). In the group with four criteria, the highest HRs were seen in the groups not including triglyceride or the blood pressure criteria (HR 3.96, 95%CI 3.57-4.59 and HR 3.79, 95%CI 3.13-4.59, respectively). The risk of CVD in those with all five criteria was in the same order (HR 3.65, 95%CI 3.33-4.01). Mendelian randomization indicated a causal role of MetS for coronary heart disease (CHD) and heart failure, but not ischemic stroke, while use of polygenetic risk scores for CHD and ischemic stroke were related to MetS criteria in a similar fashion as observational data.Conclusion Certain combinations of risk factors in individuals with the metabolic syndrome criteria showed a higher risk of future CVD than others.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Swedish Heart and Lung foundationAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the UK North West Multi-Centre Research Ethics Committee and the Swedish Ethical Review Authority. All participants provided written informed consent.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors